Left ventricular assist devices (LVADs) are becoming a more frequent life-support
intervention. Gaining an understanding of risk factors for infection and management …

Background Patients with left ventricular assist devices (LVADs) are at increased risk of GI
bleeding (GIB), primarily from GI angiodysplastic lesions (GIAD). Objective To perform meta …

Objectives: This study tested whether combined invasive hemodynamic and
echocardiographic ramp tests can help optimize patient management. Background …

Implantable left ventricular assist devices (LVAD s) became the therapy of choice in treating
end‐stage heart failure. Although survival improved substantially and is similar in currently …

Background Stroke is a major cause of mortality after left ventricular assist device (LVAD)
placement. Methods Prospectively collected data of patients with HeartMate II (n= 332) and …

Objectives We review differences in the incidence and timing of adverse events in patients
implanted with continuous-flow left ventricular assist devices (LVADs), using the Mechanical …

Background Despite the increasing use of ventricular assist devices (VADs), gender
differences in indications, hemodynamics, and outcome are not well understood. We …

Background Ischemic stroke and intracranial hemorrhage (ICH) following left ventricular
assist device (LVAD) placement are major causes of morbidity. The incidence and mortality …

Chronic heart failure (HF) is a major emerging healthcare problem, associated with a high
morbidity and mortality. Left ventricular assist devices (LVADs) have emerged as a …

Objectives: The purpose of this study was to investigate the differential impact of the 2 most
commonly available left ventricular assist device (LVAD) types on the right ventricle (RV) …